Literature DB >> 6260266

Inhibition of von Willebrand factor-dependent platelet function by increased platelet cyclic AMP and its prevention by cytoskeleton-disrupting agents.

B S Coller.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6260266

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  5 in total

1.  A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa.

Authors:  B S Coller; E I Peerschke; L E Scudder; C A Sullivan
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

2.  High shear-dependent loss of membrane integrity and defective platelet adhesion following disruption of the GPIbα-filamin interaction.

Authors:  Susan L Cranmer; Katrina J Ashworth; Yu Yao; Michael C Berndt; Zaverio M Ruggeri; Robert K Andrews; Shaun P Jackson
Journal:  Blood       Date:  2010-12-14       Impact factor: 22.113

3.  A critical role for 14-3-3zeta protein in regulating the VWF binding function of platelet glycoprotein Ib-IX and its therapeutic implications.

Authors:  Kesheng Dai; Richard Bodnar; Michael C Berndt; Xiaoping Du
Journal:  Blood       Date:  2005-06-07       Impact factor: 22.113

4.  Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor.

Authors:  H R Grainick; S B Williams; L P McKeown; M E Rick; P Maisonneuve; C Jenneau; Y Sultan
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

5.  Analysis of the roles of 14-3-3 in the platelet glycoprotein Ib-IX-mediated activation of integrin alpha(IIb)beta(3) using a reconstituted mammalian cell expression model.

Authors:  M Gu; X Xi; G D Englund; M C Berndt; X Du
Journal:  J Cell Biol       Date:  1999-11-29       Impact factor: 10.539

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.